[ad_1]
Dublin, June 15, 2021 (Global News Agency) – “Reproductive Services Market by Program, Service and End User: Global Opportunity Analysis and Industry Forecast for 2020-2027” Report has been added to ResearchAndMarkets.com provide.
The global fertility services market generated US$20,3866.1 million in 2019, and is expected to reach US$25,707,964 million by 2027, with a compound annual growth rate of 15.9% from 2020 to 2027. Fertility services are treatments that help treat patients with infertility. In vitro fertilization (IVF), surrogacy, artificial insemination, etc. are different forms of infertility services that can help couples with infertility problems, single mothers, and lesbian, gay, bisexual, and transgender (LGBT) communities to give birth .
Due to the high incidence of infertility, the new trend of delayed pregnancy in women, the advancement of fertility procedures and the increase in gamete donation rate, the global fertility service market is expected to witness substantial growth in the future. In addition, increased health awareness of fertility issues, availability of fertility treatments, increased disposable income, and favorable reimbursement policies have further contributed to market growth.
The latest innovations in IVF technology, such as embryoscopes and capsule IVF, are expected to drive the demand for fertility equipment in the future. However, maintenance is troublesome and equipment costs are high; multiple pregnancies, that is, twins, triplets, etc. related to fertility treatment; ethical considerations are expected to hinder market growth. In addition, the increase in new fertility clinics and the increase in same-sex marriages are expected to provide profitable growth opportunities in the future. In addition, the rise of birth tourism is expected to provide ample growth opportunities, especially in developing economies.
The global fertility services market is divided into programs, services, end users, and regions. According to the program, the market is divided into IVF with ICSI, surrogacy, IVF without ICSI (intracytoplasmic sperm injection), intrauterine insemination (IUI), surrogacy, etc. According to the service, it is divided into fresh non-donor, frozen non-donor, egg embryo bank, fresh donor and frozen donor. According to end users, the market is divided into fertility clinics, hospitals, surgery centers, and clinical research institutions. Analyzed the markets of North America, Europe, Asia Pacific and LAMEA by region.
Main advantage
- The study provides an in-depth analysis of the fertility services market, current trends and future estimates to clarify the upcoming investment areas
- It provides a quantitative analysis of the market from 2019 to 2027, enabling stakeholders to take advantage of current market opportunities
- Extensive analysis of the market based on programs, services and end users helps to understand industry trends
- Thorough analysis of key players and their strategies to understand the competitive outlook of the market
Key topics covered:
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Market Overview
3.1. Market definition and scope
3.2. Main findings
3.2.1. Top investment pockets
3.2.2. Best winning strategy
3.3. Porter’s five forces analysis
3.4. Government regulations
3.4.1. We
3.4.2. Europe
3.5. Market dynamics
3.5.1. Driver
3.5.1.1. Fertility rate continues to decline
3.5.1.2. Delayed pregnancy for women
3.5.1.3. Technological progress in fertility treatment
3.5.2. Constraints
3.5.2.1. The high cost of ARTs treatment in developed countries
3.5.2.2. Incomplete reimbursement policy
3.5.3. Opportunity
3.5.3.1. The rise of fertility tourism
3.6. The impact of COVID-19 on the fertility service market
3.7. Number of Fertility Service Centers
Chapter 4: Reproductive Services Market by Procedure
4.1. Overview
4.1.1. Market size and forecast
4.2. IVF with ICSI
4.2.1. Main market trends, growth factors and opportunities
4.2.2. Market size and forecast
4.3. Artificial insemination
4.3.1. Main market trends, growth factors and opportunities
4.3.2. Market size and forecast
4.4. IVF without ICSI
4.4.1. Main market trends, growth factors and opportunities
4.4.2. Market size and forecast
4.5. Surrogacy
4.5.1. Main market trends, growth factors and opportunities
4.5.2. Market size and forecast
4.6. Other
4.6.1. Main market trends, growth factors and opportunities
4.6.2. Market Scale and Forecast
Chapter 5: Reproductive Services Market by Service
5.1. Overview
5.1.1. Market size and forecast
5.2. Fresh non-donor
5.2.1. Market size and forecast
5.3. Freezing non-donor
5.3.1. Market size and forecast
5.4. Egg and embryo bank
5.4.1. Market size and forecast
5.5. Fresh donors
5.5.1. Market size and forecast
5.6. Frozen donor
5.6.1. Market size and forecast
Chapter 6: Fertility Services Market for End Users
6.1. Overview
6.1.1. Market size and forecast
6.2. Fertility Clinic
6.2.1. Market size and forecast
6.3. Hospital
6.3.1. Market scale and forecast
6.4. Surgical Center
6.4.1. Market size and forecast
6.5. Clinical research institutions
6.5.1. Market Scale and Forecast
Chapter 7: Fertility Service Market by Region
Chapter 8: Company Profile
8.1. Apollo Hospital Enterprise Co., Ltd.
8.1.1. Company Profile
8.1.2. Company snapshot
8.1.3. Operating business segment
8.1.4. Product introduction
8.1.5. Operating performance
8.1.6. Key strategic initiatives and development
8.2. Care Fertility Group Co., Ltd.
8.2.1. Company Profile
8.2.2. Company snapshot
8.2.3. Operating business segment
8.2.4. Product introduction
8.2.5. Key strategic initiatives and development
8.3. Carolina Fertility Institute
8.3.1. Company Profile
8.3.2. Company snapshot
8.3.3. Operating business segment
8.3.4. Product introduction
8.4. Urban fertility
8.4.1. Company Profile
8.4.2. Company snapshot
8.4.3. Operating business segment
8.4.4. Product introduction
8.4.5. Key strategic initiatives and development
8.5. Fertility Association Limited
8.5.1. Company Profile
8.5.2. Company snapshot
8.5.3. Operating business segment
8.5.4. Product introduction
8.6. Genia Limited
8.6.1. Company Profile
8.6.2. Company snapshot
8.6.3. Operating business segment
8.6.4. Product Introduction
8.6.5. Key strategic initiatives and development
8.7. MEDICOVER GROUP (MEDICOVER FERTILITY and FIRST EGG BANK)
8.7.1. Company Profile
8.7.2. Company snapshot
8.7.3. Operating business segment
8.7.4. Product portfolio
8.7.5. Operating performance
8.8. Monash IVF Group Co., Ltd.
8.8.1. Company Profile
8.8.2. Company snapshot
8.8.3. Operating business segment
8.8.4. Product introduction
8.8.5. Operating performance
8.8.6. Key strategic initiatives and development
8.9. PROGYNY INC.
8.9.1. Company Profile
8.9.2. Company snapshot
8.9.3. Operating business segment
8.9.4. Product Introduction
8.9.5. Operating Performance
8.9.6. Key strategic initiatives and development
8.10. Waiters Health
8.10.1. Company Profile
8.10.2. Company Snapshot
8.10.3. Operating business segment
8.10.4. Product Introduction
8.10.5. Operating performance
8.10.6. Key strategic initiatives and development
For more information about this report, please visit https://www.researchandmarkets.com/r/4s93jm
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
[ad_2]
Source link
